Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints... see more

NDAQ:APHA - Post Discussion

Aphria Inc. > Boris interview worth watching
View:
Post by CommonCentsforDollars on Mar 11, 2021 9:20pm

Boris interview worth watching

I don't own CURA and by no means am I suggesting that, I do think this interview is worth listening to for a few key points that directly apply to what Aphria/Tilray has alread been doing / Branding is the future / European market is where it is at

@ 1:25 - Boris talks about the huge opportunity the European market is

@ 4:20 - Branding is the future
  ( Keep not that CURA currently has 2 brands / TLRY-APHA currently has 21 brands)

@ 6:20 - Talks about explosive growth in medical currently in England saying the patient growth is huge at 40% month over month growth. (Keep note that Tilaphria is set up for shop in England) 

https://twitter.com/jchatterleyCNN/status/1370076390855487490

A good interview that re-enforces the Tilaphria current business model. 


eom
momo
Comment by Viking49 on Mar 12, 2021 8:20am
  Worth watching.  He estimates Europe's current Black Market does $90 billion per year business with a 10% population penetration. Change is in the air!  The next 2 years will bring positive cannabis legalization in both Europe and North America. CURA's new acquisition of EMMAC already has a distribution agreement with CC Pharma.  Partners and competitors ...more  
Aphria Inc.